Granules Pharma Gets US FDA Tentative Approval for Generic ADZENYS XR-ODT
Granules Pharmaceuticals Inc has received tentative approval from the US FDA for its generic version of Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT), which will be manufactured at the company’s US-based facility in Chantilly, Virginia.
Virginia | 22/12/2025 | By News Bureau
AstraZeneca opens expanded manufacturing facility in Texas
AstraZeneca’s USD 445 million investment will support global manufacturing of Lokelma
Virginia | 16/10/2025 | By Dineshwori | 141
New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies.<br />
Virginia | 10/10/2025 | By Dineshwori | 126
Lilly to Establish USD 5 Billion API Manufacturing Facility in Virginia
The new site in Virginia marks the first of four new US manufacturing sites that Lilly plans to announce this year.
Virginia | 17/09/2025 | By Dineshwori | 121
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy